Skip to main content

Table 1 Baseline characteristics of the enrolled patients

From: Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection

Variable HCC group (n = 41) LC group (n = 55) CHB group (n = 97) HC group (n = 14)
Sex (male/female) 35/6 40/15 72/25 10/4
Age (years) 60 (52.7–64.2) 51 (41–59) 41 (29.5–48.5) 45 (32.7–49.7)
HBeAg(−/+) 24/17 28/27 34/63 NA
HBVDNA(−/+) 19/22 17/38 19/78 NA
HBsAg 4879 (2490–6796) 4781 (2515–6819) 3769 (1264–5728.5) NA
ALT (U/L) 51 (32.7–99.3) 42 (26–89) 118 (43–272.5) 17.5 (12–25.2)
AST (U/L) 86 (49–178.5) 57 (39–85) 56 (33–134) 13.5 (12–17.2)
TBIL (umol/L) 24.9 (14.8–50.9) 30.4 (18.7–60.2) 18.5 (11.6–46.25) 11 (8.7–13.2)
ALB (g/L) 35.8 (32.8–39.9) 32.7 (29.1–38.1) 41.3 (37.4–44.5) 45 (44.5–54)
PTA (%) 75 (66–80.3) 68 (55–80) 94 (86–103) 84.5 (79.5–90.5
AFP (ng/ml) 444.5 (254.5–1693.5) 25.8 (58.9–181.27) 181.2 (8.2–118.3) 12 (96.6–13)
WBC (E+ 09/L) 5.5 (3.9–9.6) 5.8 (3.3–6.7) 5.3 (4.6–6.4) 5.8 (5.3–7.0)
HGB (g/L) 129 (110–143.5) 129 (101–140) 150 (140.5–155) 141.5 (137.9–146)
PLT (E+ 09/L) 134 (98.7–211.3) 98 (78–154) 188 (154.3–229.5) 193 (172.5–206)
  1. Quantitative variables are expressed as the median (25th percentile; 75th percentile)
  2. CHB Chronic hepatitis B, HCs Healthy controls, HBsAg Hepatitis B surface antigen, HBeAg Hepatitis B e antigen, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ALB Albumin, TBIL Total bilirubin, PTA Prothrombin activity, AFP α-fetoprotein, WBC White blood cell, HGB Hemoglobin, PLT Platelet, NA Not available